Anemia is associated with increased risk of contrast‑induced acute kidney injury: A Systematic Review and Meta-analysis

References

• Lei L, Xue Y, Guo Z, et al. Population attributable risk estimates of risk factors for contrast-induced acute kidney injury following coronary angiography: a cohort study. BMC Cardiovasc Disord. 2020;20:289
   PubMed Web of Science ®Google Scholar
• Rudnick MR, Leonberg-Yoo AK, Litt HI, et al. The controversy of contrast-induced nephropathy with intravenous contrast: what is the risk? Am J Kidney Dis. 2020;75:105–113.
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–2264.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Qiu H, Hu XY, et al. Risk factors of contrast-induced acute kidney injury in patients undergoing emergency percutaneous coronary intervention. Chin Med J (Engl). 2017;130:45–50.
   PubMed Web of Science ®Google Scholar
• Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol. 2004;183:1673–1689.
   PubMed Web of Science ®Google Scholar
• Do C. Intravenous Contrast: Friend or foe? A Review on contrast-induced nephropathy. Adv Chronic Kidney Dis. 2017;24:147–149.
   PubMed Web of Science ®Google Scholar
• Al’Aref SJ, Singh G, van Rosendael AR, et al. Determinants of in-hospital mortality after percutaneous coronary intervention: a machine learning approach. J Am Heart Assoc. 2019;8:e011160.
   PubMed Web of Science ®Google Scholar
• Guo W, Liu Y, Chen JY, et al. Hyperuricemia is an independent predictor of contrast-induced acute kidney injury and mortality in patients undergoing percutaneous coronary intervention. Angiology. 2015;66:721–726.
   PubMed Web of Science ®Google Scholar
• Sreenivasan J, Zhuo M, Khan MS, et al. Anemia (Hemoglobin ≤ 13 g/dL) as a risk factor for contrast-induced acute kidney injury following coronary angiography. Am J Cardiol. 2018;122:961–965.
   PubMed Web of Science ®Google Scholar
• Kim J-H, Yang JH, Choi S-H, et al. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease. Am J Cardiol. 2014;114:1830–1835.
   PubMed Web of Science ®Google Scholar
• Liu C-W, Liao P-C, Chen K-C, et al. SYNTAX score of infarct-related artery other than the number of coronary balloon inflations and deflations as an independent predictor of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction. Acta Cardiol Sin. 2017;33:362–376.
   PubMed Web of Science ®Google Scholar
• Chong E, Shen L, Poh KK, et al. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention. Singapore Med J. 2012;53:164–169.
   PubMed Web of Science ®Google Scholar
• Chong E, Poh KK, Liang S, et al. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol. 2010;23:451–459.
   PubMed Web of Science ®Google Scholar
• Hsieh TM, Tsai TH, Liu YW, et al. Risk factors for contrast-induced nephropathy and their association with mortality in patients with blunt splenic injuries. Int J Surg. 2016;35:69–75.
   PubMed Web of Science ®Google Scholar
• Kurtul A, Murat SN, Yarlioglues M, et al. Procalcitonin as an early predictor of contrast-induced acute kidney injury in patients with acute coronary syndromes who underwent percutaneous coronary intervention. Angiology. 2015;66:957–963.
   PubMed Web of Science ®Google Scholar
• Li WH, Li DY, Han F, et al. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions. Int Urol Nephrol. 2013;45:1065–1070.
   PubMed Web of Science ®Google Scholar
• Abe D, Sato A, Hoshi T, et al. Clinical predictors of contrast-induced acute kidney injury in patients undergoing emergency versus elective percutaneous coronary intervention. Circ J. 2014;78:85–91.
   PubMed Web of Science ®Google Scholar
• Banda J, Duarte R, Dickens C, et al. Risk factors and outcomes of contrast-induced nephropathy in hospitalised South Africans. S Afr Med J. 2016;106:699–703.
   PubMedGoogle Scholar
• Grossman PM, Ali SS, Aronow HD, et al. Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: incidence, risk factors, and outcomes as observed in the blue cross blue shield of michigan cardiovascular consortium, J Interv Cardiol. 2017;30:274–280
   Google Scholar
• Sato A, Aonuma K, Watanabe M, et al. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study. Int J Cardiol. 2017;227:424–429.
   PubMed Web of Science ®Google Scholar
• Shacham Y, Gal-Oz A, Leshem-Rubinow E, et al. Association of admission hemoglobin levels and acute kidney injury among myocardial infarction patients treated with primary percutaneous intervention. Can J Cardiol. 2015;31:50–55.
   PubMed Web of Science ®Google Scholar
• Liese AD, Hense HW, Löwel H, et al. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World health organization monitoring trends and determinants in cardiovascular diseases. Epidemiology. 1999;10:391–397.
   PubMed Web of Science ®Google Scholar
• Saito Y, Watanabe M, Aonuma K, et al. Proteinuria and reduced estimated glomerular filtration rate are independent risk factors for contrast-induced nephropathy after cardiac catheterization. Circ J. 2015;79:1624–1630.
   PubMed Web of Science ®Google Scholar
• James MT, Samuel SM, Manning MA, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6:37–43.
   PubMed Web of Science ®Google Scholar
• Christiansen C. X-ray contrast media–an overview. Toxicology. 2005;209:185–187.
   PubMed Web of Science ®Google Scholar
• Silver SA, Shah PM, Chertow GM, et al. Risk prediction models for contrast induced nephropathy: systematic review. BMJ. 2015;351:h5401
   PubMedGoogle Scholar
• Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1113–1119.
   PubMed Web of Science ®Google Scholar
• Murakami R, Kumita S, Hayashi H, et al. Anemia and the risk of contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT. Eur J Radiol. 2013;82:e521–4.
   PubMed Web of Science ®Google Scholar
• Reed WW, Diehl LF. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med. 1991;151:501–505.
   PubMed Web of Science ®Google Scholar
• Johannes T, Mik EG, Nohé B, et al. Acute decrease in renal microvascular PO2 during acute normovolemic hemodilution. Am J Physiol Renal Physiol. 2007;292:F796–803.
   PubMed Web of Science ®Google Scholar
• Kumar AB, Suneja M. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology. 2011;114:964–970.
   PubMed Web of Science ®Google Scholar
• Pannu N, Manns B, Lee H, et al. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65:1366–1374.
   PubMed Web of Science ®Google Scholar
• Katholi RE, Woods WT Jr., Taylor GJ, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32:64–71.
   PubMed Web of Science ®Google Scholar
• Agmon Y, Peleg H, Greenfeld Z, et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest. 1994;94:1069–1075.
   PubMed Web of Science ®Google Scholar
• Hizóh I, Sträter J, Schick CS, et al. Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transplant. 1998;13:911–918.
   PubMed Web of Science ®Google Scholar